These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 33558663)

  • 21. B7-H3 ligand expression by prostate cancer: a novel marker of prognosis and potential target for therapy.
    Roth TJ; Sheinin Y; Lohse CM; Kuntz SM; Frigola X; Inman BA; Krambeck AE; McKenney ME; Karnes RJ; Blute ML; Cheville JC; Sebo TJ; Kwon ED
    Cancer Res; 2007 Aug; 67(16):7893-900. PubMed ID: 17686830
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Neoadjuvant enoblituzumab in localized prostate cancer: a single-arm, phase 2 trial.
    Shenderov E; De Marzo AM; Lotan TL; Wang H; Chan S; Lim SJ; Ji H; Allaf ME; Chapman C; Moore PA; Chen F; Sorg K; White AM; Church SE; Hudson B; Fields PA; Hu S; Denmeade SR; Pienta KJ; Pavlovich CP; Ross AE; Drake CG; Pardoll DM; Antonarakis ES
    Nat Med; 2023 Apr; 29(4):888-897. PubMed ID: 37012549
    [TBL] [Abstract][Full Text] [Related]  

  • 23. B7-H3 Expression in Breast Cancer and Brain Metastasis.
    Joshi V; Beecher K; Lim M; Stacey A; Feng Y; Jat PS; Duijf PHG; Simpson PT; Lakhani SR; McCart Reed AE
    Int J Mol Sci; 2024 Apr; 25(7):. PubMed ID: 38612786
    [TBL] [Abstract][Full Text] [Related]  

  • 24. B7-H3 promotes multiple myeloma cell survival and proliferation by ROS-dependent activation of Src/STAT3 and c-Cbl-mediated degradation of SOCS3.
    Lin L; Cao L; Liu Y; Wang K; Zhang X; Qin X; Zhao D; Hao J; Chang Y; Huang X; Liu B; Zhang J; Lu J; Ge Q
    Leukemia; 2019 Jun; 33(6):1475-1486. PubMed ID: 30573782
    [TBL] [Abstract][Full Text] [Related]  

  • 25. B7-H3 and B7x are highly expressed in human prostate cancer and associated with disease spread and poor outcome.
    Zang X; Thompson RH; Al-Ahmadie HA; Serio AM; Reuter VE; Eastham JA; Scardino PT; Sharma P; Allison JP
    Proc Natl Acad Sci U S A; 2007 Dec; 104(49):19458-63. PubMed ID: 18042703
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Examining initial treatment and survival among men with metastatic prostate cancer: An analysis from the CaPSURE registry.
    Borno HT; Cowan JE; Zhao S; Broering JM; Carroll PR; Ryan CJ
    Urol Oncol; 2020 Oct; 38(10):793.e1-793.e11. PubMed ID: 32782182
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Association of B7-H3 expression with racial ancestry, immune cell density, and androgen receptor activation in prostate cancer.
    Mendes AA; Lu J; Kaur HB; Zheng SL; Xu J; Hicks J; Weiner AB; Schaeffer EM; Ross AE; Balk SP; Taplin ME; Lack NA; Tekoglu E; Maynard JP; De Marzo AM; Antonarakis ES; Sfanos KS; Joshu CE; Shenderov E; Lotan TL
    Cancer; 2022 Jun; 128(12):2269-2280. PubMed ID: 35333400
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Loss of PTEN Expression Detected by Fluorescence Immunohistochemistry Predicts Lethal Prostate Cancer in Men Treated with Prostatectomy.
    Hamid AA; Gray KP; Huang Y; Bowden M; Pomerantz M; Loda M; Sweeney CJ
    Eur Urol Oncol; 2019 Sep; 2(5):475-482. PubMed ID: 31411988
    [TBL] [Abstract][Full Text] [Related]  

  • 29. B7-H3 is overexpressed in patients suffering osteosarcoma and associated with tumor aggressiveness and metastasis.
    Wang L; Zhang Q; Chen W; Shan B; Ding Y; Zhang G; Cao N; Liu L; Zhang Y
    PLoS One; 2013; 8(8):e70689. PubMed ID: 23940627
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Novel immune scoring dynamic nomograms based on B7-H3, B7-H4, and HHLA2: Potential prediction in survival and immunotherapeutic efficacy for gallbladder cancer.
    Lv C; Han S; Wu B; Liang Z; Li Y; Zhang Y; Lang Q; Zhong C; Fu L; Yu Y; Xu F; Tian Y
    Front Immunol; 2022; 13():984172. PubMed ID: 36159808
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Enhancing surgical outcomes: accurate identification and removal of prostate cancer with B7-H3-targeted NIR-II molecular imaging.
    Tian Y; Shen H; Li L; Jia X; Liu J; Hu Z; Wang L; Tian J
    Eur J Nucl Med Mol Imaging; 2024 Jul; 51(9):2569-2582. PubMed ID: 38647671
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Association of mTOR Pathway Markers and Clinical Outcomes in Patients with Intermediate-/High-risk Prostate Cancer: Long-Term Analysis.
    Barata PC; Magi-Galluzzi C; Gupta R; Dreicer R; Klein EA; Garcia JA
    Clin Genitourin Cancer; 2019 Oct; 17(5):366-372. PubMed ID: 31262501
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation Challenges in the Validation of B7-H3 as Oral Tongue Cancer Prognosticator.
    Sieviläinen M; Wirsing AM; Hyytiäinen A; Almahmoudi R; Rodrigues P; Bjerkli IH; Åström P; Toppila-Salmi S; Paavonen T; Coletta RD; Hadler-Olsen E; Salo T; Al-Samadi A
    Head Neck Pathol; 2021 Jun; 15(2):469-478. PubMed ID: 32959211
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Assessment of combined expression of B7-H3 and B7-H4 as prognostic marker in esophageal cancer patients.
    Chen L; Xie Q; Wang Z; Shi L; Wu C; Jiang J
    Oncotarget; 2016 Nov; 7(47):77237-77243. PubMed ID: 27764786
    [TBL] [Abstract][Full Text] [Related]  

  • 35. B7-H3 over expression in prostate cancer promotes tumor cell progression.
    Yuan H; Wei X; Zhang G; Li C; Zhang X; Hou J
    J Urol; 2011 Sep; 186(3):1093-9. PubMed ID: 21784485
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immune checkpoint of B7-H3 in cancer: from immunology to clinical immunotherapy.
    Zhao B; Li H; Xia Y; Wang Y; Wang Y; Shi Y; Xing H; Qu T; Wang Y; Ma W
    J Hematol Oncol; 2022 Oct; 15(1):153. PubMed ID: 36284349
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical Significance of the Expression of Co-Stimulatory Molecule B7-H3 in Papillary Thyroid Carcinoma.
    Zhao B; Huang Z; Zhu X; Cai H; Huang Y; Zhang X; Zhang Z; Lu H; An C; Niu L; Li Z
    Front Cell Dev Biol; 2022; 10():819236. PubMed ID: 35493085
    [No Abstract]   [Full Text] [Related]  

  • 38. Expression status of PD-L1 and B7-H3 in mesothelioma.
    Matsumura E; Kajino K; Abe M; Ohtsuji N; Saeki H; Hlaing MT; Hino O
    Pathol Int; 2020 Dec; 70(12):999-1008. PubMed ID: 33027549
    [TBL] [Abstract][Full Text] [Related]  

  • 39. B7-H3 and B7-H4 expression in phyllodes tumors of the breast detected by RNA in situ hybridization and immunohistochemistry: Association with clinicopathological features and T-cell infiltration.
    Kim GE; Kim NI; Park MH; Lee JS
    Tumour Biol; 2018 Nov; 40(11):1010428318815032. PubMed ID: 30486739
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A review of B7-H3 and B7-H4 immune molecules and their role in ovarian cancer.
    Fauci JM; Straughn JM; Ferrone S; Buchsbaum DJ
    Gynecol Oncol; 2012 Nov; 127(2):420-5. PubMed ID: 22910694
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.